Biohit appoints Quick Test distributor in Germany

| Source: Biohit Oyj

Biohit Oyj Press Release June 26th, 2014 at 5:50 p.m. local time (EEST)

Biohit Oyj has appointed Bestbion dx GmbH to distribute its range of Quick Test products in Germany. Bestbion dx, based in Germany, specializes in the field of microbiology, infectious diseases, cardiology, immunology and point-of-care testing, and with 30 years of industry experience will bring considerable expertise to Biohit’s distribution network. The agreement covers Biohit’s full range of Quick Tests.

CEO Semi Korpela, Biohit Oyj: ‘We are excited to be partnering with Bestbion. The Biohit Quick Test range fits well with the distribution channel of Bestbion in Germany.  One example of this is that Celiac diagnosis is now be available from a fingertip blood sample within ten minutes, which is user-friendly for pediatric patients.´

CEO Bernd Stammel, Bestbion dx GmbH: ‘Bestbion dx is delighted to start distributing Biohit’s Quick Tests in Germany. Biohit’s products are a substantial accompaniment to Bestbion’s comprehensive list of gastroenterology products. Now Bestbion’s product portfolio will include the fastest available quick test for Helicobacter pylori diagnosis. We’re really looking forward to a beneficial and long term relationship.’

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group.

Bestbion in brief

Bestbion dx GmbH specializes in the distribution of innovative diagnostics.  The company has extensive, long-standing experience in the marketing of diagnostic products and reagents and focuses in the field of microbiology, infectious diseases, cardiology, immunology and point-of-care testing.